NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

Summary by News Medical

The National Institutes of Health has initiated a multi-site clinical trial evaluating an investigational antiviral for the treatment of COVID-19.

Published 4 months ago · Washington, United States

News Articles

More
Filters

All

Left

Center

Right

The Star Kuala Lumpur

U.S. starts trial to evaluate antiviral in adults hospitalized with COVID-19

LOS ANGELES, Feb. 15 (Xinhua) -- The U.S. National Institutes of Health (NIH) has initiated a multi-site clinical trial evaluating an investigational antiviral for the treatment of COVID-19, the agency announced on Wednesday. Read full story

4 months ago·Malaysia

Read Full Article

News Medical

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

The National Institutes of Health has initiated a multi-site clinical trial evaluating an investigational antiviral for the treatment of COVID-19.

4 months ago·United States

Read Full Article

Bloomberg Law

NIH to Study Shionogi’s Covid Antiviral in Hospitalized Patients

US researchers have begun a final-stage study of Shionogi & Co.’s Xocova antiviral in hospitalized Covid-19 patients to see whether it can help improve care as the number of available therapies diminishes.

4 months ago

Read Full Article

The Perfect Enemy

NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19 – National Institutes of Health (.gov)

NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19 National Institutes of Health (.gov)View Full Coverage on Google News…

4 months ago

Read Full Article

National Institutes of Health (NIH)…

NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19

Trial protocol may be adapted to evaluate additional therapeutics.

4 months ago·Washington, United States

Read Full Article

India West

The United States starts a trial to evaluate antivirals in adults hospitalized with Covid

4 months ago

Read Full Article

Bias Distribution

50% of the sources are Center

L 25%

C 50%

R 25%

See less detail

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

News Articles

U.S. starts trial to evaluate antiviral in adults hospitalized with COVID-19

U.S. starts trial to evaluate antiviral in adults hospitalized with COVID-19

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

NIH to Study Shionogi’s Covid Antiviral in Hospitalized Patients

NIH to Study Shionogi’s Covid Antiviral in Hospitalized Patients

NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19 – National Institutes of Health (.gov)

NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19 – National Institutes of Health (.gov)

NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19

NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19

The United States starts a trial to evaluate antivirals in adults hospitalized with Covid

The United States starts a trial to evaluate antivirals in adults hospitalized with Covid

Similar News Topics

Bias Distribution

Similar News Topics

Time & Location

News Coverage Details

Bias Distribution

Similar News Topics

Bias Distribution